Related Experiment Videos
Effect of hyperlipidaemia on pulmonary diffusing capacity for carbon monoxide.
Thorax
|April 1, 1979
Summary
This study found that moderate hyperlipidaemia does not affect pulmonary diffusion capacity for carbon monoxide (DLCO). Testing in patients and healthy subjects confirmed no significant impact on lung function, even after fat emulsion infusion.
Area of Science:
- Pulmonary Medicine
- Cardiovascular Health
- Respiratory Physiology
Background:
- Conflicting evidence exists regarding the impact of hyperlipidaemia on pulmonary diffusing capacity for carbon monoxide (DLCO).
- Understanding this relationship is crucial for managing patients with cardiovascular risk factors and potential respiratory complications.
Purpose of the Study:
- To investigate the effect of hyperlipidaemia on pulmonary diffusing capacity for carbon monoxide (DLCO) in humans.
- To determine if serum lipid levels correlate with changes in lung diffusion capacity.
Main Methods:
- Measured carbon monoxide transfer factor per unit alveolar volume (TLCO/VA or KCO) using the single breath method.
- Studied 25 hyperlipidaemic patients and 3 healthy subjects.
- Administered intravenous fat emulsion (Intralipid) and monitored lipid levels and TLCO/VA.
Main Results:
- Non-smoking hyperlipidaemic patients showed normal TLCO/VA levels.
- Smokers with hyperlipidaemia exhibited a slight reduction in TLCO/VA, but no correlation with lipid concentrations.
- Plasma exchange and dietary changes significantly reduced triglycerides without affecting TLCO/VA.
- Intralipid infusion increased triglyceride levels but did not alter TLCO/VA in healthy subjects.
Conclusions:
- Moderate hyperlipidaemia does not appear to significantly affect pulmonary diffusion capacity (DLCO).
- The findings suggest that lipid levels alone are not a primary determinant of lung diffusion in the studied populations.